Shenzhen Original Advanced Compounds Co., Ltd.
SSE:603991.SS
54.19 (CNY) • At close May 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 364.563 | 239.419 | 129.524 | 128.136 | 311.316 | 461.866 | 569.778 | 427.446 | 351.113 | 300.893 | 272.44 | 218.878 | 153.381 |
| Cost of Revenue
| 309.935 | 199.653 | 119.183 | 119.777 | 297.487 | 408.649 | 440.153 | 330.47 | 255.155 | 211.746 | 189.169 | 149.409 | 105.249 |
| Gross Profit
| 54.627 | 39.767 | 10.341 | 8.359 | 13.829 | 53.217 | 129.624 | 96.976 | 95.958 | 89.148 | 83.271 | 69.469 | 48.132 |
| Gross Profit Ratio
| 0.15 | 0.166 | 0.08 | 0.065 | 0.044 | 0.115 | 0.227 | 0.227 | 0.273 | 0.296 | 0.306 | 0.317 | 0.314 |
| Reseach & Development Expenses
| 14.887 | 13.351 | 5.059 | 6.805 | 15.699 | 26.212 | 21.972 | 19.435 | 19.184 | 18.933 | 19.963 | 20.243 | 8.645 |
| General & Administrative Expenses
| 11.129 | 20.505 | 11.531 | 5.963 | 12.436 | 19.38 | 17.081 | 11.671 | 4.116 | 5.145 | 3.762 | 28.882 | 17.781 |
| Selling & Marketing Expenses
| 2.894 | 4.077 | 4.294 | 3.145 | 7.66 | 24.325 | 25.171 | 15.786 | 14.537 | 13.16 | 11.18 | 9.163 | 9.34 |
| SG&A
| 14.023 | 42.787 | 15.824 | 9.108 | 20.097 | 43.705 | 42.252 | 27.456 | 18.653 | 18.305 | 14.942 | 38.045 | 27.122 |
| Other Expenses
| 36.672 | 18.882 | 9.177 | 11.283 | 13.641 | 16.501 | 10.911 | 6.259 | 11.502 | 2.432 | 9.087 | 1.406 | 1.64 |
| Operating Expenses
| 65.581 | 75.019 | 30.06 | 27.196 | 49.437 | 86.418 | 77.226 | 51.823 | 48.184 | 46.448 | 42.33 | 39.036 | 27.891 |
| Operating Income
| -10.954 | -34.8 | 1.87 | -18.836 | -35.608 | -33.201 | 39.157 | 41.876 | 40.173 | 35.979 | 33.868 | 21.87 | 11.563 |
| Operating Income Ratio
| -0.03 | -0.145 | 0.014 | -0.147 | -0.114 | -0.072 | 0.069 | 0.098 | 0.114 | 0.12 | 0.124 | 0.1 | 0.075 |
| Total Other Income Expenses Net
| 0.012 | -0.034 | 0.011 | -0.144 | -17.172 | -24.703 | -0.217 | 2.98 | 3.604 | 2.432 | 0.532 | 1.401 | -5.983 |
| Income Before Tax
| -10.942 | -34.834 | -21.283 | -55.621 | -52.781 | -57.905 | 38.94 | 44.856 | 43.778 | 38.411 | 34.4 | 23.27 | 13.202 |
| Income Before Tax Ratio
| -0.03 | -0.145 | -0.164 | -0.434 | -0.17 | -0.125 | 0.068 | 0.105 | 0.125 | 0.128 | 0.126 | 0.106 | 0.086 |
| Income Tax Expense
| 6.909 | 3.621 | -4.462 | -2.192 | -4.701 | -0.85 | 4.731 | 6.899 | 6.323 | 4.748 | 4.319 | 2.317 | 1.934 |
| Net Income
| -30.534 | -44.423 | -16.821 | -53.429 | -48.08 | -57.054 | 34.209 | 37.957 | 37.455 | 33.662 | 30.081 | 20.953 | 11.268 |
| Net Income Ratio
| -0.084 | -0.186 | -0.13 | -0.417 | -0.154 | -0.124 | 0.06 | 0.089 | 0.107 | 0.112 | 0.11 | 0.096 | 0.073 |
| EPS
| -0.41 | -0.6 | -0.23 | -0.72 | -0.65 | -0.77 | 0.46 | 0.54 | 0.67 | 0.6 | 0.73 | 0.54 | 0.29 |
| EPS Diluted
| -0.41 | -0.6 | -0.23 | -0.72 | -0.65 | -0.77 | 0.46 | 0.54 | 0.67 | 0.6 | 0.73 | 0.54 | 0.29 |
| EBITDA
| 13.757 | -12.043 | 14.413 | -36.872 | -28.366 | -31.826 | 66.146 | 55.652 | 54.473 | 49.093 | 45.81 | 33.991 | 21.297 |
| EBITDA Ratio
| 0.038 | -0.05 | 0.111 | -0.288 | -0.091 | -0.069 | 0.116 | 0.13 | 0.155 | 0.163 | 0.168 | 0.155 | 0.139 |